Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging

82Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Ultrasound contrast agents (CA) are generally micron-sized stabilized gas bubbles, injected IV. However, to penetrate beyond the vasculature and accumulate in targets such as tumors, CA must be an order of magnitude smaller. We describe a method of achieving nanometer-sized, surfactant-stabilized CA by differential centrifugation. High g force was shown to destroy bubble integrity. Optimal conditions (300 rpm for 3 min) produced an agent with a mean diameter of 450 nm, which gave 25.5 dB enhancement in vitro at a dose of 10 μL/mL, with a 13 min half-life. In vivo, the CA produced excellent power Doppler and grey-scale pulse inversion harmonic images at low acoustic power when administered. In vivo dose-response curves obtained in three rabbits showed enhancement between 20 and 25 dB for dosages above 0.025 mL/kg. These results encourage further investigation of the possible diagnostic and therapeutic benefits of using nanoparticles as CA, including passive targeting and accumulation in tumors. © 2006 World Federation for Ultrasound in Medicine & Biology.

Cite

CITATION STYLE

APA

Wheatley, M. A., Forsberg, F., Dube, N., Patel, M., & Oeffinger, B. E. (2006). Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound in Medicine and Biology, 32(1), 83–93. https://doi.org/10.1016/j.ultrasmedbio.2005.08.009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free